Research Article
Hepatic Arterial Therapy with Drug-Eluting Beads in the Management of Metastatic Bronchogenic Carcinoma to the Liver: A Multi-Institutional Registry
Table 2
Bead catheter infusion outcomes.
| | total treatments |
| Number of bead courses | Median 2 (range 1β5) | Technical success | 97% | Dosage delivered (median, range) | 75βmg (19β200) | Total hepatic dose exposure | 150 (0β458) | β1 | 150 (0β200) | β2 | 150 (79β190) | β3 | 325 | β>3 | 458 | Bead Size Utilized | | β100β300 | 24 | β300β500 | 5 | β500β700 | 1 | Complications | 14% | Extrahepatic infusion | 0 | Hematologic changes | | βWBC | β1.9 (β9994.4β9991.8) | βHGB | 0.1 (β9989.1β9987.5) | βBilirubin | 0 (β9998.7β9998.8) |
|
|